Complete Price Breakdown: Wegovy vs Mounjaro Costs
Why Switching From Wegovy To Mounjaro Pricing Transparency Matters
When switching from Wegovy to Mounjaro, hidden fees can significantly impact your treatment budget and decision-making process. Many online pharmacies advertise low headline prices but add consultation fees (£20-50), prescription charges (£10-25), and admin costs that can double your actual spend. EverydayMeds eliminates this pricing confusion by including everything in our upfront cost. Whether you're switching from Wegovy to Mounjaro or comparing both options, our transparent approach means you can make informed decisions without financial surprises.
This transparency becomes particularly important for weight management medications like Wegovy and Mounjaro, which require long-term commitment for optimal results. Hidden fees compound over time, turning an apparently affordable treatment into a significant ongoing expense. Our all-inclusive pricing model ensures you understand your total investment from day one, whether you're maintaining Wegovy or switching from Wegovy to Mounjaro for clinical reasons.
Switching From Wegovy To Mounjaro: Complete Pricing Structure
Our transparent pricing for patients switching from Wegovy to Mounjaro starts at £79.99 for 0.25mg starter doses, progressing to £209.99 for 2.4mg maintenance doses. Unlike competitors, these prices include clinical assessment, prescriber review, prescription costs, and next-day cold-chain delivery. New customers use code FIRST40 at checkout, whilst returning customers apply code DOSE25 to access these transparent rates. Both Wegovy and Mounjaro follow identical pricing structures, making cost comparison straightforward when switching from Wegovy to Mounjaro.
Our bundle options provide additional value through convenience rather than hidden savings calculations. The Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) is priced at £369.99. These bundles ensure treatment continuity and reduce ordering frequency – particularly valuable when switching from Wegovy to Mounjaro and wanting Reliable Supply during your transition period. All bundle prices remain fully inclusive with no additional charges.
Clinical Evidence Supporting Switching From Wegovy To Mounjaro Decisions
Understanding the clinical basis for switching from Wegovy to Mounjaro helps justify the transparent pricing investment in either treatment option. Wegovy (semaglutide) demonstrated significant efficacy in the STEP trial programme, with patients achieving average weight reductions of approximately 15% at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). Mounjaro (tirzepatide) operates through a dual GIP/GLP-1 receptor mechanism, compared to Wegovy's single GLP-1 pathway.
Both treatments require identical clinical monitoring and prescriber oversight, explaining why switching from Wegovy to Mounjaro maintains the same transparent pricing structure. The prescription-only medicine status of both drugs necessitates comprehensive clinical assessment and ongoing medical supervision. EverydayMeds' transparent pricing reflects these regulatory requirements without hidden clinical fees that some providers charge separately.
How Wegovy Works: Understanding Your Current Treatment
Before switching from Wegovy to Mounjaro, it's essential to understand your current treatment mechanism to make informed decisions. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in your intestines after eating. This mechanism works by reducing appetite, promoting earlier satiety after smaller meals, and may help reduce food cravings by acting on brain appetite centres. Wegovy is administered as a once-weekly injection using Novo Nordisk's FlexTouch pen system. The treatment requires mandatory dose escalation from 0.25mg through to 2.4mg maintenance, with each stage serving specific tolerance-building purposes. Wegovy must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal results, making it part of a comprehensive weight management approach rather than a standalone solution.
Streamlined Ordering Process For Switching From Wegovy To Mounjaro
Our transparent ordering process for switching from Wegovy to Mounjaro eliminates hidden consultation fees through efficient online systems. Complete our 3-minute clinical assessment covering your medical history, current medications, and weight management goals – this assessment fee is included in our advertised prices. Prescriber review typically takes 3 working days (24-hour express option available), with qualified UK clinicians evaluating your suitability for either Wegovy continuation or switching from Wegovy to Mounjaro based on your individual circumstances. Once approved, next-day cold-chain delivery ensures temperature-controlled transport maintaining medication efficacy, with delivery costs included in your treatment price. Our GPhC-registered pharmacy (#9012878) handles all aspects of your prescription without separate pharmacy dispensing fees. This integrated approach eliminates the multiple charging points that create hidden costs with other providers.
Storage and Practical Considerations When Switching From Wegovy To Mounjaro
Practical differences between Wegovy and Mounjaro can influence your switching decision, particularly regarding storage flexibility and travel convenience. Wegovy offers superior storage advantages, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigeration at 2-8°C before first use, making home storage straightforward with standard refrigerator temperatures. The FlexTouch pen delivery system for Wegovy provides reliable dosing with clear dose indicators, whilst both treatments follow similar weekly injection schedules. When switching from Wegovy to Mounjaro, your prescriber will guide appropriate transition timing and any necessary washout periods. Dose escalation remains mandatory for both treatments, ensuring tolerance development and minimising gastrointestinal side effects during your switching process.
Treatment Continuity Advantages When Switching From Wegovy To Mounjaro
Switching from Wegovy to Mounjaro through EverydayMeds provides treatment continuity advantages impossible with traditional pharmacy models charging separate fees. Our integrated clinical team can oversee your entire switching process without referring between different consultation services or prescription providers. This continuity becomes particularly valuable when managing potential side effects or dosing adjustments during your transition period.
The transparent pricing structure means you can budget accurately for both treatments when switching from Wegovy to Mounjaro, avoiding financial disruption during your transition. Our bundle options provide treatment security through Reliable Supply, reducing the risk of treatment gaps that could compromise your weight management progress. This comprehensive approach acknowledges that switching from Wegovy to Mounjaro requires careful clinical management rather than simple prescription substitution.
Complete Your Switching From Wegovy To Mounjaro Journey Today
Ready to explore switching from Wegovy to Mounjaro with complete price transparency? Start your clinical assessment at https://everydaymeds.co.uk/collections/wegovy where our qualified prescribers can evaluate both treatment options based on your individual circumstances. Use code FIRST40 if you're new to EverydayMeds, or code DOSE25 for returning customers to access our transparent pricing from £79.99. Our approach eliminates the hidden fees and surprise charges that complicate switching from Wegovy to Mounjaro with other providers. Both treatments are available through our GPhC-registered pharmacy (#9012878) with identical transparent pricing structures, clinical oversight, and next-day delivery service. Whether you continue with Wegovy or complete your switch to Mounjaro, you'll have complete clarity on costs and treatment expectations from day one.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
